(Q38897946)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25786779%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

title

Targeting ferritin receptors for the selective delivery of imaging and therapeutic agents to breast cancer cells (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25786779%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25786779%20AND%20SRC:MED&resulttype=core&format=json

Simonetta Geninatti Crich

3 March 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25786779%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Laura Conti

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25786779%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Roberto Ruiu

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25786779%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Silvio Aime

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25786779%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

author name string

M Cadenazzi

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25786779%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

S Lanzardo

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25786779%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

D Alberti

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25786779%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

J C Cutrin

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25786779%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

language of work or name

English

0 references

publication date

1 April 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25786779%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25786779%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

volume

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25786779%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

issue

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25786779%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

page(s)

6527-6533

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25786779%20AND%20SRC:MED&resulttype=core&format=json

Breast cancer in young women in Latin America: an unmet, growing burden.

3 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1039%2FC5NR00352K

The landscape of medical oncology in Europe by 2020.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5NR00352K

New targeted therapies for breast cancer: A focus on tumor microenvironmental signals and chemoresistant breast cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5NR00352K

Recent progress in nanomedicine: therapeutic, diagnostic and theranostic applications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5NR00352K

Nanotheranostics - application and further development of nanomedicine strategies for advanced theranostics

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5NR00352K

Theranostic nanomedicine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5NR00352K

Protein-based nanomedicine platforms for drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5NR00352K

Ferritins as nanoplatforms for imaging and drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5NR00352K

RGD-modified apoferritin nanoparticles for efficient drug delivery to tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5NR00352K

Epidermal growth factor-ferritin H-chain protein nanoparticles for tumor active targeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5NR00352K

Apoferritin-templated yttrium phosphate nanoparticle conjugates for radioimmunotherapy of cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5NR00352K

Binding and uptake of H-ferritin are mediated by human transferrin receptor-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5NR00352K

H-ferritin-nanocaged doxorubicin nanoparticles specifically target and kill tumors with a single-dose injection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5NR00352K

Ferritin: a novel mechanism for delivery of iron to the brain and other organs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5NR00352K

Scara5 is a ferritin receptor mediating non-transferrin iron delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5NR00352K

A Tf-independent iron transport system required for organogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5NR00352K

Genetic and epigenetic silencing of SCARA5 may contribute to human hepatocellular carcinoma by activating FAK signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5NR00352K

Iron uptake mediated by binding of H-ferritin to the TIM-2 receptor in mouse cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5NR00352K

Tim-2 is the receptor for H-ferritin on oligodendrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5NR00352K

Serum ferritin: Past, present and future

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5NR00352K

Role of ferritin alterations in human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5NR00352K

Curcumin--from molecule to biological function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5NR00352K

The effect of curcumin on breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5NR00352K

Curcumin nanoformulations: a review of pharmaceutical properties and preclinical studies and clinical data related to cancer treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5NR00352K

Curcumin nanoformulations: a future nanomedicine for cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5NR00352K

Curcumin/Gd loaded apoferritin: a novel "theranostic" agent to prevent hepatocellular damage in toxic induced acute hepatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5NR00352K

Ferritin stimulates breast cancer cells through an iron-independent mechanism and is localized within tumor-associated macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5NR00352K

Relaxation induced by ferritin: a better understanding for an improved MRI iron quantification

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5NR00352K

Effect of magnetic field and iron content on NMR proton relaxation of liver, spleen and brain tissues.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5NR00352K

Effect of the intracellular localization of a Gd-based imaging probe on the relaxation enhancement of water protons

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5NR00352K

Capecitabine Versus Classical Cyclophosphamide, Methotrexate, and Fluorouracil As First-Line Chemotherapy for Advanced Breast Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5NR00352K

Cellular compartmentalization of internalized paramagnetic liposomes strongly influences both T1and T2relaxivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5NR00352K

Reduction/dissolution of a beta-MnOOH nanophase in the ferritin cavity to yield a highly sensitive, biologically compatible magnetic resonance imaging agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5NR00352K

Magnetic Resonance Visualization of Tumor Angiogenesis by Targeting Neural Cell Adhesion Molecules with the Highly Sensitive Gadolinium-Loaded Apoferritin Probe

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5NR00352K

21 January 2018

Identifiers

DOI

10.1039/C5NR00352K

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25786779%20AND%20SRC:MED&resulttype=core&format=json

release_ipjkq3t55jfjjmrlq6zx3u5vmq

3 March 2020

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/ipjkq3t55jfjjmrlq6zx3u5vmq

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25786779%20AND%20SRC:MED&resulttype=core&format=json